1 / 6

Myelodysplastic Syndrome (MDS) Drugs Market Size, Growth, Trends and Forecast to 2023

Myelodysplastic Syndrome (MDS) Drugs Market Size, Growth, Trends and Forecast to 2023

bhagyashribhole123
Download Presentation

Myelodysplastic Syndrome (MDS) Drugs Market Size, Growth, Trends and Forecast to 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Myelodysplastic Syndrome (MDS) Drugs Market Research Report - Forecast to 2023 Global Industry Survey, Growth, Competitive Landscapeand Forecasts to 2023 CREATED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

  2. Myelodysplastic Syndrome (MDS) Drugs MarketResearch Report - Forecast to 2023 Research Across Sectors to Give Impetus to Global Myelodysplastic Syndrome (MDS) Drugs Market 2023 • The Global Myelodysplastic Syndrome (MDS) Drugs Market is expected to grow significantly over the forecast period. The Myelodysplastic Syndrome (MDS) drugs market held a valuation of USD 1,581.59 million in 2018 and is projected to register a CAGR of 10.1% over the forecast period. • The increasing participation of key players is one of the key factors driving the Myelodysplastic Syndrome (MDS) drugs market. In 2018, the US Food and Drug Administration approved generic injectable product decitabine for Lupin Ltd. There are various other MDS medications available in the market. • Various other factors that are driving the MDS drugs market are the promotion of clinical studies related to MDS, increasing geriatric population, rise in regulatory approvals, and growing participation of generic drugs manufactures. • However, the risk of infections during blood transfusions and side-effects of chemotherapy may hamper market growth over the forecast period. Browse Report Details @ https://www.marketresearchfuture.com/reports/myelodysplastic-syndrome-drugs-market-8134 www.marketresearchfuture.com

  3. Myelodysplastic Syndrome (MDS) Drugs Market Research Report - Forecast to 2023 Segmentation: • The global Myelodysplastic Syndrome (MDS) drugs market is segmented based on product, type of syndrome, route of administration, end user, and region. • Based on product, the global Myelodysplastic Syndrome (MDS) drugs market is further segmented into chemotherapy, immunomodulatory drugs, and others. The chemotherapy segment is sub-segmented as conventional drugs and hypomethylating drugs. Hypomethylating drugs include Azacitidine and Decitabine. Conventional drugs comprise Cytarabine, Daunorubicin, and Idarubicin. • The MDS drugs market at a global level is segmented on type of syndrome into refractory cytopenia with multilineage dysplasia, refractory anemia, refractory anemia with excess blasts, refractory anemia with ringed sideroblasts, refractory cytopenia with multilineage dysplasia, and others. • Based on the route of administration, the market is segmented into oral, parenteral, and others. The MDS drugs available in the market are administered through parenteral route, for instance, intravenous or subcutaneous. Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/8134 www.marketresearchfuture.com

  4. Myelodysplastic Syndrome (MDS) Drugs Market Research Report - Forecast to 2023 Application & Major Players in this Research: Myelodysplastic Syndrome (MDS) Drugs Market Prominent Players: • BluePoint Laboratories • Celgene Corporation • Celgene Europe Limited • Reddy's Laboratories, Inc. • Johnson & Johnson • Lupin Ltd Corporation • Otsuka America Pharmaceutical Inc. • Sandoz • Shilpa Medicare Limited • Sun Pharmaceutical Industries Inc. Get Discount @ https://www.marketresearchfuture.com/check-discount/8134 www.marketresearchfuture.com

  5. Myelodysplastic Syndrome (MDS) Drugs Market Research Report - Forecast to 2023 About Us: Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future. www.marketresearchfuture.com

  6. MARKET RESEARCH FUTURE THANK YOU salesteam@marketresearchfuture.com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK) www.marketresearchfuture.com

More Related